Celldex Therapeutics Inc (CLDX)
Operating Cash Flow Growth
-26.52%
TTM · Period ending:
CLDX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-26.52%period ending
Latest reported-26.52%period ending
CLDX TTM Cash from Operations YoY % (-163.64% → -26.52%)
Year-over-year change
High-resolution chart · PNG
CLDX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -135.5401% | |
| -120.5152% | |
| 48.0987% | |
| 35.9071% | |
| 46.2378% | |
| 47.4234% | |
| 4.0551% | |
| 15.1515% | |
| -20.9877% | |
| -25.3333% | |
| -15.5844% | |
| -32% | |
| -1.25% | |
| 17.5824% | |
| 20.6186% | |
| -8.6957% | |
| -3.8961% | |
| -21.3333% | |
| -22.7848% | |
| 40% | |
| 24.5098% | |
| 26.4706% | |
| 13.1868% | |
| -55.4054% | |
| -54.5455% | |
| -72.8814% | |
| -65.4545% | |
| -23.3333% | |
| -11.8644% | |
| -7.2727% | |
| -36.3636% | |
| -34.0909% | |
| -34.1463% | |
| -29.4118% | |
| -25.7143% | |
| -36.6667% | |
| -163.6364% |